{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:01:17Z","timestamp":1784037677095,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00925-4","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T17:12:30Z","timestamp":1748452350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational and biological modeling of IGF1R inhibition for multifocal medulloblastoma"],"prefix":"10.1038","volume":"5","author":[{"given":"Alyssa G.","family":"Almer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6103-4448","authenticated-orcid":false,"given":"Samuel V.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Svalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie L.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-8723","authenticated-orcid":false,"given":"Sonja","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Cheshier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1234-7880","authenticated-orcid":false,"given":"Bryn A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8666-3152","authenticated-orcid":false,"given":"Noah E.","family":"Berlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-7487","authenticated-orcid":false,"given":"Charles","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"925_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/MPH.0b013e3181bbc502","volume":"31","author":"S Partap","year":"2009","unstructured":"Partap, S. et al. Medulloblastoma incidence has not changed over time: a CBTRUS study. J. Pediatr. Hematol. Oncol. 31, 970\u2013971 (2009).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"925_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.tpj.6500077","volume":"2","author":"MC Fruhwald","year":"2002","unstructured":"Fruhwald, M. C. & Plass, C. Metastatic medulloblastoma\u2013therapeutic success through molecular target identification?. Pharmacogenomics J. 2, 7\u201310 (2002).","journal-title":"Pharmacogenomics J."},{"key":"925_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1215\/15228517-1-3-232","volume":"1","author":"RJ Packer","year":"1999","unstructured":"Packer, R. J. et al. Medulloblastoma: clinical and biologic aspects. Neuro Oncol. 1, 232\u2013250 (1999).","journal-title":"Neuro Oncol."},{"key":"925_CR4","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","volume":"23","author":"JR Geyer","year":"2005","unstructured":"Geyer, J. R. et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children\u2019s Cancer Group. J. Clin. Oncol. 23, 7621\u20137631 (2005).","journal-title":"J. Clin. Oncol."},{"key":"925_CR5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2013.52.3290","volume":"32","author":"I Moxon-Emre","year":"2014","unstructured":"Moxon-Emre, I. et al. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J. Clin. Oncol. 32, 1760\u20131768 (2014).","journal-title":"J. Clin. Oncol."},{"key":"925_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465\u2013472 (2012).","journal-title":"Acta Neuropathol."},{"key":"925_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","volume":"46","author":"RD Kortmann","year":"2000","unstructured":"Kortmann, R. D. et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT \u201891. Int. J. Radiat. Oncol. Biol. Phys. 46, 269\u2013279 (2000).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"925_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","volume":"131","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy, V. et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol. 131, 821\u2013831 (2016).","journal-title":"Acta Neuropathol."},{"key":"925_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep27012","volume":"6","author":"MN Svalina","year":"2016","unstructured":"Svalina, M. N. et al. IGF1R as a key target in high risk, metastatic medulloblastoma. Sci. Rep. 6, 27012 (2016).","journal-title":"Sci. Rep."},{"key":"925_CR10","doi-asserted-by":"publisher","first-page":"T69","DOI":"10.1530\/JME-17-0311","volume":"61","author":"F Hakuno","year":"2018","unstructured":"Hakuno, F. & Takahashi, S. I. IGF1 receptor signaling pathways. J. Mol. Endocrinol. 61, T69\u2013T86 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"925_CR11","first-page":"833","volume":"64","author":"XM He","year":"1991","unstructured":"He, X. M. et al. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Investig. 64, 833\u2013843 (1991).","journal-title":"Lab Investig."},{"key":"925_CR12","first-page":"472","volume":"130","author":"HS Friedman","year":"1988","unstructured":"Friedman, H. S. et al. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am. J. Pathol. 130, 472\u2013484 (1988).","journal-title":"Am. J. Pathol."},{"key":"925_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00005072-198509000-00003","volume":"44","author":"PF Jacobsen","year":"1985","unstructured":"Jacobsen, P. F., Jenkyn, D. J. & Papadimitriou, J. M. Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J. Neuropathol. Exp. Neurol. 44, 472\u2013485 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"925_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00006123-199308000-00018","volume":"33","author":"C Raffel","year":"1993","unstructured":"Raffel, C. et al. Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 33, 301\u2013305 (1993).","journal-title":"Neurosurgery"},{"key":"925_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann, S. et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Investig. 85, 1163\u20131171 (2005).","journal-title":"Lab Investig."},{"key":"925_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinform. 18, 529 (2017).","journal-title":"BMC Bioinform."},{"key":"925_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676 (2012).","journal-title":"Nat. Methods"},{"key":"925_CR18","doi-asserted-by":"publisher","first-page":"A101","DOI":"10.1158\/1535-7163.TARG-09-A101","volume":"8","author":"PL Clemens","year":"2009","unstructured":"Clemens, P. L. et al. Abstract A101: BMS-754807, an oral dual IGF-1R\/IR inhibitor: first-in-human single-dose study of safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Mol. Cancer Ther. 8, A101\u2013A101 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"925_CR19","unstructured":"Geraldine, A. & Van der Auwera, B. D. O. C. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra 1st edn (O\u2019Reilly Media, Inc., 2020)."},{"key":"925_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"925_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"925_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"925_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"925_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","journal-title":"Genome Biol."},{"key":"925_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott, P. A. et al. The whole-genome landscape of medulloblastoma subtypes. Nature 547, 311 (2017).","journal-title":"Nature"},{"key":"925_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12987-022-00304-4","volume":"19","author":"M Khani","year":"2022","unstructured":"Khani, M. et al. Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology. Fluids Barriers CNS 19, 8 (2022).","journal-title":"Fluids Barriers CNS"},{"key":"925_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12987-020-00185-5","volume":"17","author":"M Khani","year":"2020","unstructured":"Khani, M. et al. In vitro and numerical simulation of blood removal from cerebrospinal fluid: comparison of lumbar drain to Neurapheresis therapy. Fluids Barriers CNS 17, 23 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"925_CR28","doi-asserted-by":"publisher","first-page":"0810121","DOI":"10.1115\/1.4040401","volume":"140","author":"M Khani","year":"2018","unstructured":"Khani, M. et al. Anthropomorphic model of intrathecal cerebrospinal fluid dynamics within the spinal subarachnoid space: spinal cord nerve roots increase steady-streaming. J. Biomech. Eng. 140, 0810121\u201308101215 (2018).","journal-title":"J. Biomech. Eng."},{"key":"925_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12987-017-0085-y","volume":"14","author":"LR Sass","year":"2017","unstructured":"Sass, L. R. et al. A 3D subject-specific model of the spinal subarachnoid space with anatomically realistic ventral and dorsal spinal cord nerve rootlets. Fluids Barriers CNS 14, 36 (2017).","journal-title":"Fluids Barriers CNS"},{"key":"925_CR30","doi-asserted-by":"publisher","first-page":"879098","DOI":"10.3389\/fnimg.2022.879098","volume":"1","author":"A Seiner","year":"2022","unstructured":"Seiner, A. et al. Investigation of human intrathecal solute transport dynamics using a novel in vitro cerebrospinal fluid system analog. Front. Neuroimaging 1, 879098 (2022).","journal-title":"Front. Neuroimaging"},{"key":"925_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bspc.2017.03.019","volume":"36","author":"MM Lagan\u00e0","year":"2017","unstructured":"Lagan\u00e0, M. M. et al. Intracranial volumetric changes govern cerebrospinal fluid flow in the Aqueduct of Sylvius in healthy adults. Biomed. Signal Process. Control 36, 84\u201392 (2017).","journal-title":"Biomed. Signal Process. Control"},{"key":"925_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/jmri.25160","volume":"44","author":"JR Bapuraj","year":"2016","unstructured":"Bapuraj, J. R. et al. Cerebrospinal fluid velocity amplitudes within the cerebral aqueduct in healthy children and patients with Chiari I malformation. J. Magn. Reson. Imaging 44, 463\u2013470 (2016).","journal-title":"J. Magn. Reson. Imaging"},{"key":"925_CR33","doi-asserted-by":"publisher","first-page":"0210061","DOI":"10.1115\/1.4044308","volume":"142","author":"M Khani","year":"2020","unstructured":"Khani, M. et al. Impact of neurapheresis system on intrathecal cerebrospinal fluid dynamics: a computational fluid dynamics study. J. Biomech. Eng. 142, 0210061\u20130210069 (2020).","journal-title":"J. Biomech. Eng."},{"key":"925_CR34","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1007\/s10439-016-1681-8","volume":"44","author":"K Tangen","year":"2016","unstructured":"Tangen, K. et al. Clearance of subarachnoid hemorrhage from the cerebrospinal fluid in computational and in vitro models. Ann. Biomed. Eng. 44, 3478\u20133494 (2016).","journal-title":"Ann. Biomed. Eng."},{"key":"925_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1115\/1.2768376","volume":"129","author":"V Kurtcuoglu","year":"2007","unstructured":"Kurtcuoglu, V. et al. Mixing and modes of mass transfer in the third cerebral ventricle: a computational analysis. J. Biomech. Eng. 129, 695\u2013702 (2007).","journal-title":"J. Biomech. Eng."},{"key":"925_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000028659","volume":"28","author":"IG Bloomfield","year":"1998","unstructured":"Bloomfield, I. G., Johnston, I. H. & Bilston, L. E. Effects of proteins, blood cells and glucose on the viscosity of cerebrospinal fluid. Pediatr. Neurosurg. 28, 246\u2013251 (1998).","journal-title":"Pediatr. Neurosurg."},{"key":"925_CR37","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s10439-015-1355-y","volume":"43","author":"SH Pahlavian","year":"2015","unstructured":"Pahlavian, S. H. et al. Neural tissue motion impacts cerebrospinal fluid dynamics at the cervical medullary junction: a patient-specific moving-boundary computational model. Ann. Biomed. Eng. 43, 2911\u20132923 (2015).","journal-title":"Ann. Biomed. Eng."},{"key":"925_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12987-019-0164-3","volume":"17","author":"LR Sass","year":"2020","unstructured":"Sass, L. R. et al. Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients. Fluids Barriers CNS 17, 4 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"925_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.rli.0000100892.87214.49","volume":"39","author":"O Baledent","year":"2004","unstructured":"Baledent, O. et al. Relationship between cerebrospinal fluid and blood dynamics in healthy volunteers and patients with communicating hydrocephalus. Investig. Radiol. 39, 45\u201355 (2004).","journal-title":"Investig. Radiol."},{"key":"925_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnagi.2019.00087","volume":"11","author":"J Attier-Zmudka","year":"2019","unstructured":"Attier-Zmudka, J. et al. Decreased cerebrospinal fluid flow is associated with cognitive deficit in elderly patients. Front. Aging Neurosci. 11, 87 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"925_CR41","doi-asserted-by":"publisher","first-page":"20131189","DOI":"10.1098\/rsif.2013.1189","volume":"11","author":"B Siyahhan","year":"2014","unstructured":"Siyahhan, B. et al. Flow induced by ependymal cilia dominates near-wall cerebrospinal fluid dynamics in the lateral ventricles. J. R. Soc. Interface 11, 20131189 (2014).","journal-title":"J. R. Soc. Interface"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00925-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T17:12:32Z","timestamp":1748452352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00925-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00925-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.K. has or has had sponsored research agreements with Eli Lily, Roche-Genentech, and Cardiff Oncology, as well as research collaborations with Novartis, and is co-founder of Tio Companies and Teo Therapeutics. Artisan Biopharma is a wholly owned subsidiary of cc-TDI. B.A.M. is an employee of Alcyone Therapeutics and has been a scientific advisory board member for Novoron Biosciences, Alcyone Lifesciences, Anuncia Medical, Chiari and Syringomyelia Foundation, The International Society for Hydrocephalus and CSF Disorders, and The International CSF Dynamics Society. B.A.M. has received sponsored research funding from NIH, NASA, Biogen Inc., Genentech Inc., Voyager Therapeutics Inc., KBR Wyle, Alcyone Lifesciences Inc., and Minnetronix Inc. B.A.M. has served as a consultant to Flux Neuroscience, Genentech, Roche, Minnetronix, SwanBio Therapeutics, Praxis Medicines, Cerebral Therapeutics, CereVasc, InviCRO, Neurosyntec, Behavior Imaging, Anuncia Medical, and Voyager Therapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}